+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shionogi and Co ltd - logo

Shionogi develops pharmaceutical products for pain, pediatric conditions, infectious diseases, cardiovascular diseases, diabetes, and women's health. It offers products in the form of injections, chewable and oral tablets, capsules, and oral suspensions. It has been expanding its pipeline and its portfolio of marketed products to encompass other therapeutic areas as well, with programs in metabolic conditions and pain management. The company was founded in 2010 and is based in Florham Park, New Jersey.

Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • February 2023
  • 92 Pages
  • Global
From
Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 194 Pages
  • Global
From
Narcolepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Narcolepsy Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 363 Pages
  • Global
From
Influenza Treatment Market Size, Share & Trends Analysis Report by Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Influenza Treatment Market Size, Share & Trends Analysis Report by Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 130 Pages
  • Global
From
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Influenza Medication Market by Drug Class, Delivery Form, Influenza Type, Distribution Channel, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Influenza Medication Market by Drug Class, Delivery Form, Influenza Type, Distribution Channel, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 182 Pages
  • Global
From
Antiviral Therapeutics Market by Drug, Therapy, Distribution - Global Forecast 2025-2030 - Product Thumbnail Image

Antiviral Therapeutics Market by Drug, Therapy, Distribution - Global Forecast 2025-2030

  • Report
  • October 2024
  • 189 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Epidermolysis Bullosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 136 Pages
  • Global
From
Narcolepsy Drugs Market by Type, Therapeutics Type - Global Forecast 2025-2030 - Product Thumbnail Image

Narcolepsy Drugs Market by Type, Therapeutics Type - Global Forecast 2025-2030

  • Report
  • October 2024
  • 197 Pages
  • Global
From
Central Nervous System (CNS) Stimulant Drugs Market 2024-2028 - Product Thumbnail Image

Central Nervous System (CNS) Stimulant Drugs Market 2024-2028

  • Report
  • July 2024
  • 165 Pages
  • Global
From
Peripheral Neuropathy Treatment Market 2024-2028 - Product Thumbnail Image

Peripheral Neuropathy Treatment Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 383 Pages
  • Global
From
Chikungunya Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chikungunya Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 111 Pages
  • Global
From
Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 173 Pages
  • Global
From
Klebsiella Pneumoniae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Klebsiella Pneumoniae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 138 Pages
  • Global
From
Resistant Pseudomonas aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Resistant Pseudomonas aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 46 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 51 Pages
  • Global
From
Loading Indicator